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Is a device used in this study?
If yes:
◦ Is it approved?
◦ Is it exempt?
◦ What is the risk?

 SR/NSR determination

•

The practice of medicine

•

The conduct of research

– A class of activities designed solely to enhance the
well being of an individual patient.
– Not monitored by the IRB
– Off label use of an approved device not subject to
IRB oversight.
– a class of activities designed to develop or
contribute to generalizable knowledge.
– Different set of duties and obligations
– Subject to IRB review and federal regulatory
guidelines

•

A medical device is an instrument, apparatus,
implement, machine, contrivance, implant, in vitro
reagent, or other similar or related article, including
any component, part, or accessory, which is—

– recognized in the official National Formulary, or the United
States Pharmacopeia, or any supplement to them,
– intended for use in the diagnosis of disease or other
conditions, or in the cure, mitigation, treatment, or
prevention of disease, in man or other animals, or
– intended to affect the structure or any function of the body
of man or other animals, and

•

which does not achieve its primary intended purposes
through chemical action within or on the body of man
or other animals and which is not dependent upon
being metabolized for the achievement of its primary
intended purposes (21 U.S.C. 321(h)).



If you are using the device in a clinical
investigation, it is by definition
investigational.
◦ That does not mean it always needs an IDE

 Might be exempt
 Might be NSR (subject to abbreviated requirements)

All Device
Investigations

Subject to
IDE
regulations

Significant Risk (SR):
Full IDE Requirements

Exempt from
IDE
Regulations

Non-significant Risk
(NSR)
Abbreviated IDE
Requirements



Practice of Medicine

◦ Off label therapeutic use within the practitionerpatient relationship



Basic Physiologic Research

◦ Investigating a physiologic principle
◦ No intent to develop for marketing
◦ Only using to address the research question, not
safety and effectiveness



Is it being used within its approved indication
◦ Is the device modified at all?
◦ How is it being used in the study?
◦ What is on the PMA or 510(k) approval and how
does that compare to the use you are proposing in
your study
◦ Does the use of the device in this study add risk to
the subject?

•

A diagnostic device, if the sponsor complies
with applicable requirements in 809.10(c) and
if the testing:
– Is noninvasive,
– Does not require an invasive sampling procedure
that presents significant risk,
– Does not by design or intention introduce energy
into a subject, and
– Is not used as a diagnostic procedure without
confirmation of the diagnosis by another, medically
established diagnostic product or procedure.



A device undergoing consumer preference
testing, testing of a modification, or testing
of a combination of two or more devices in
commercial distribution, if the testing is not
for the purpose of determining safety or
effectiveness and does not put subjects at

risk.





Studies to support marketing application
Studies that will be submitted to the FDA
Studies of new indications

•

IRB must determine if:

– Significant Risk: requires application to the FDA and
assignment of IDE #, FDA reporting and monitoring
requirements
– Non-significant risk: abbreviated IDE requirements,
IRB review, no application to the FDA

•
•

NOT the same as the FDA class
NOT the same as the minimal risk
determination.

•

•

•

•

Is intended as an implant and presents a potential
for serious risk to the health, safety, or welfare of a
subject;
Is purported or represented to be for use
supporting or sustaining human life and presents a
potential for serious risk to the health, safety, or
welfare of a subject;
Is for a use of substantial importance in
diagnosing, curing, mitigating, or treating disease,
or otherwise preventing impairment of human
health and presents a potential for serious risk to
the health, safety, or welfare of a subject; or
Otherwise presents a potential for serious risk to
the health, safety, or welfare of a subject.



Everything else









If previously decided by the FDA, sponsor
should provide the determination letter.
If no previous FDA decision, sponsor makes
initial determination.
IRB must review and either agree or modify
the sponsor determination if they disagree.
FDA is final arbiter if submitted.

•
•

Review sponsor/PI information.
What is the basis for the risk?

– Proposed use of the device, not the device alone.

•

What is the nature of the harm that may
result?

– Potential for serious risk to health, safety or welfare

•

Are there any additional procedures with
potential for harm?

– Harm of the procedure should be considered, not
just the device.



Consequences of getting it wrong

◦ You may have unnecessarily exposed the
participants to risk.
◦ Your study may get closed prior to completion.
◦ You may not be allowed to use the data at all.
◦ You will be conducting an investigation in violation
of federal regulatory guidelines and may be subject
to sanctions by the institution and/or federal
agencies.



Emergency use of an unapproved device is
permissible if:

◦ The patient has a life-threatening condition that
needs immediate treatment;
◦ No generally acceptable alternative treatment for
the condition exists; and
◦ Because of the immediate need to use the device,
here is no time to use existing procedures to get
FDA approval



IRB requirements

◦ If time, you should submit a Form 11 to the IRB
before the emergency use. If not, you must submit
afterwards
◦ If possible, informed consent should be obtained.
◦ Obtain sponsor authorization
◦ Independent physician assessment.





Must be reported to FDA and IRB w/in 5 days
of use .
IRB requires 30 day follow up







Appropriate if the investigational device is the
only option available for a patient with a
serious or life-threatening condition.
Differs from emergency use in that there is
time to seek prior FDA and IRB approval,
which is required for it to be used.
Specific monitoring and reporting
requirements apply



We are available to help you with this
process!

